Baird Capital Portfolio Company Amphora Medical Closes $35.5 Million Series B Financing

Baird Capital portfolio company Amphora Medical, Inc., a Minneapolis-based developer of medical devices to treat overactive bladder (OAB), announced today the closing of a $35.5 million Series B financing. Amphora will use the proceeds from this financing to fund the U.S. pivotal study for its Selective Bladder Denervation System in women with OAB. 

For more information, please read Amphora Medical's news release